Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Regeneron
Company Monitoring Page for Regeneron
latest headlines for company on cafepharma
Regeneron Could Have a Big Catalyst Coming in 2022
Motley Fool
Sat, 10/9/21 - 11:11 pm
Tags:
Regeneron
,
Libtayo
,
cervical cancer
,
FDA
,
Sanofi
J&J spends $100M upfront, with $1.2B in biobucks, to join Roche and Regeneron in bispecific blood cancer race
Fierce Biotech
Mon, 10/4/21 - 11:08 am
Tags:
JNJ
,
Xencor
,
biobucks
,
Roche
,
Regeneron
,
bispecific antibodies
,
blood cancers
,
plamotamab
Regeneron's COVID-19 antibody cocktail reduces hospitalization risk by 71%, study shows
Beckers Hospital Review
Sun, 10/3/21 - 08:39 pm
Tags:
Regeneron
,
COVID-19
,
antibodies
Is the cancer immunotherapy market up for disruption as AstraZeneca, Regeneron-Sanofi, cheaper Chinese offerings line up?
Fierce Pharma
Sun, 10/3/21 - 08:27 pm
Tags:
cancer
,
oncology
,
cancer immunotherapy
,
Merck
,
AstraZeneca
,
Regeneron
,
Sanofi
ESMO21: Libtayo extends survival in first-line NSCLC, challenging Keytruda
Pharmaforum
Mon, 09/20/21 - 11:07 am
Tags:
Sanofi
,
Regeneron
,
Libtayo
,
ESMO
,
non-small cell lung cancer
,
Merck
,
Keytruda
Surging US demand triggers new $2.9B purchase of Regeneron's Covid-19 antibodies
Endpoints
Wed, 09/15/21 - 10:47 am
Tags:
Regeneron
,
COVID-19
,
antibodies
,
government contract
Pfizer's abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, but key questions remain
Fierce Biotech
Mon, 08/30/21 - 11:03 am
Tags:
Pfizer
,
abrocitinib
,
atopic dermatitis
,
Dupixent
,
Sanofi
,
Regeneron
,
clinical trials
It's back: Eli Lilly's COVID-19 antibody combo makes its return after 2 months on the sidelines
Fierce Pharma
Mon, 08/30/21 - 10:59 am
Tags:
Eli Lilly
,
antibodies
,
COVID-19
,
Regeneron
,
GSK
,
bamlanivimab-etesevimab
Brii gets a Covid-19 antibody boost
EP Vantage
Wed, 08/25/21 - 11:09 am
Tags:
Brii Biosciences
,
COVID-19
,
antibodies
,
Regeneron
Regeneron earns mid-stage win for higher dose of Eylea, hoping to refresh its sales pitch
Endpoints
Tue, 08/24/21 - 10:51 am
Tags:
Regeneron
,
Eylea
,
clinical trials
,
wet age-related macular degeneration
Gilead, Regeneron, AstraZeneca and more encourage FDA to expand patient reported outcome guidance
Endpoints
Mon, 08/23/21 - 11:07 am
Tags:
Gilead Sciences
,
Regeneron
,
AstraZeneca
,
FDA
,
PROs
,
oncology
,
clinical trials
,
patient-reported outcomes
Novartis says trials back Beovu safety in diabetic eye disease
Pharmaforum
Tue, 08/17/21 - 10:08 am
Tags:
Novartis
,
Beovu
,
diabetic macular edema
,
Bayer
,
Regeneron
,
Eylea
Lilly, swinging at the king, shows Dupixent rival works in phase 3, but wait for key figures goes on
Fierce Biotech
Mon, 08/16/21 - 12:25 pm
Tags:
Eli Lilly
,
lebrikizumab
,
Sanofi
,
Regeneron
,
Dupixent
,
atopic dermatitis
,
clinical trials
Sanofi and Regeneron solidify Dupixent TV ad lead, topping July pharma spenders again, trailed by AbbVie and Novo Nordisk
Fierce Pharma
Fri, 08/6/21 - 12:22 pm
Tags:
DTC advertising
,
television ads
,
Dupixent
,
Regeneron
,
Sanofi
Regeneron drug extends survival in lung cancer trial, lifting company's hopes in field
BioPharma Dive
Thu, 08/5/21 - 11:02 pm
Tags:
Regeneron
,
Sanofi
,
Libtayo
,
clinical trials
,
lung cancer
With expanded FDA nod, Regeneron's COVID-19 antibody drug can help the immunocompromised
Fierce Pharma
Mon, 08/2/21 - 10:56 am
Tags:
Regeneron
,
FDA
,
COVID-19
,
REGEN-COV
Lilly’s lebrikizumab looks to outdo Dupixent
EP Vantage
Mon, 08/2/21 - 10:48 am
Tags:
Eli Lilly
,
lebrikizumab
,
atopic dermatitis
,
Dupixent
,
Sanofi
,
Regeneron
New Drug Proves to Ease the Itch for Chronic Spontaneous Urticaria
BioSpace
Sat, 07/31/21 - 10:18 pm
Tags:
Regeneron
,
Sanofi
,
Dupixent
,
clinical trials
,
chronic spontaneous urticaria
FDA okays Regeneron COVID-19 antibody as preventive in high-risk settings
Yahoo/Reuters
Sat, 07/31/21 - 10:11 pm
Tags:
Regeneron
,
FDA
,
COVID-19
,
Emergency Use Authorization
,
antibodies
AstraZeneca teams up with Regeneron for obesity-busting drug pact focused on genetics
Fierce Biotech
Tue, 07/27/21 - 10:29 am
Tags:
AstraZeneca
,
GPR75
,
obesity
,
Regeneron
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.